Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN MICHAEL NOWINS

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1912047176
CMS profile
1157910
Location
LAS VEGAS, NV

General Payments · PY2018–2024

$867.31

  • Reported across 68 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$195.66

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $195.66 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $161.39 14
Phathom Pharmaceuticals, Inc. $21.60 1
Organon LLC $12.67 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $62.57 4
PY2019 $60.34 3
PY2020 $85.62 5
PY2021 $51.66 4
PY2022 $243.45 22
PY2023 $168.01 14
PY2024 $195.66 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novo Nordisk Inc $9.33 01/26/2024 Food and Beverage Undisputed 01/23/2026 1097209452 CMS
Novo Nordisk Inc $20.62 02/10/2024 Food and Beverage Undisputed 01/23/2026 1097218081 CMS
Novo Nordisk Inc $10.56 03/22/2024 Food and Beverage Undisputed 01/23/2026 1097129320 CMS
Novo Nordisk Inc $9.67 04/05/2024 Food and Beverage Undisputed 01/23/2026 1096901233 CMS
Novo Nordisk Inc $11.11 04/26/2024 Food and Beverage Undisputed 01/23/2026 1096722924 CMS
Novo Nordisk Inc $9.88 05/23/2024 Food and Beverage Undisputed 01/23/2026 1096594416 CMS
Novo Nordisk Inc $11.23 06/28/2024 Food and Beverage Undisputed 01/23/2026 1097215844 CMS
Novo Nordisk Inc $9.76 07/19/2024 Food and Beverage Undisputed 01/23/2026 1096687791 CMS
Novo Nordisk Inc $9.65 08/16/2024 Food and Beverage Undisputed 01/23/2026 1097410753 CMS
Novo Nordisk Inc $10.78 09/06/2024 Food and Beverage Undisputed 01/23/2026 1097193506 CMS
Novo Nordisk Inc $7.52 10/03/2024 Food and Beverage Undisputed 01/23/2026 1097537747 CMS
Novo Nordisk Inc $21.19 11/01/2024 Food and Beverage Undisputed 01/23/2026 1096742451 CMS
Novo Nordisk Inc $11.05 11/15/2024 Food and Beverage Undisputed 01/23/2026 1097284408 CMS
Novo Nordisk Inc $9.04 12/12/2024 Food and Beverage Undisputed 01/23/2026 1096904877 CMS
Organon Llc $12.67 04/11/2024 Food and Beverage Undisputed 01/23/2026 1136188038 CMS
Phathom Pharmaceuticals, Inc. $21.60 08/02/2024 Food and Beverage Undisputed 01/23/2026 1151103217 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.